- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic lymphocytic leukaemia
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 16096
Publisher
Springer Nature
Online
2017-01-18
DOI
10.1038/nrdp.2016.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P-048Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study
- (2016) K. Mirkin et al. ANNALS OF ONCOLOGY
- IL-4 enhances expression and function of surface IgM in CLL cells
- (2016) M. M. Aguilar-Hernandez et al. BLOOD
- High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
- (2016) B. Cui et al. BLOOD
- Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
- (2016) B. L. Lampson et al. BLOOD
- Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
- (2016) Joseph A. Fraietta et al. BLOOD
- The Dohner fluorescencein situhybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
- (2016) Daniel L. Van Dyke et al. BRITISH JOURNAL OF HAEMATOLOGY
- A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells
- (2016) Sandrine Medves et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia
- (2016) J. Ojha et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
- (2016) C. Vitale et al. CLINICAL CANCER RESEARCH
- Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
- (2016) Giuseppe Spadaro et al. CLINICAL IMMUNOLOGY
- Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
- (2016) Sujata Bhoi et al. Epigenetics
- Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
- (2016) Massimo Gentile et al. EUROPEAN JOURNAL OF CANCER
- Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells
- (2016) Andrew Getahun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Second-generation inhibitors of Bruton tyrosine kinase
- (2016) Jingjing Wu et al. Journal of Hematology & Oncology
- An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
- (2016) LANCET ONCOLOGY
- First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
- (2016) Barbara Eichhorst et al. LANCET ONCOLOGY
- Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
- (2016) Stephan Stilgenbauer et al. LANCET ONCOLOGY
- Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL
- (2016) C Maurer et al. LEUKEMIA
- Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
- (2016) Julio C. Chavez et al. LEUKEMIA RESEARCH
- Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia
- (2016) Tomas Radivoyevitch et al. LEUKEMIA RESEARCH
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
- (2016) Christopher C Oakes et al. NATURE GENETICS
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein-Barr virus-positive diffuse large B cell lymphoma arising from a chronic lymphocytic leukemia: Overlapping features with classical Hodgkin lymphoma
- (2016) Yun-An Chen et al. PATHOLOGY INTERNATIONAL
- Richter syndrome: pathogenesis and management
- (2016) Davide Rossi et al. SEMINARS IN ONCOLOGY
- Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
- (2016) Jan A. Burger et al. Nature Communications
- Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
- (2016) Sonja I. Berndt et al. Nature Communications
- Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
- (2016) Richard Greil et al. Lancet Haematology
- Insecticide exposure and farm history in relation to risk of lymphomas and leukemias in the Women's Health Initiative observational study cohort
- (2015) Leah H. Schinasi et al. ANNALS OF EPIDEMIOLOGY
- Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) B. Eichhorst et al. ANNALS OF ONCOLOGY
- No evidence of transmission of chronic lymphocytic leukemia through blood transfusion
- (2015) H. Hjalgrim et al. BLOOD
- Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
- (2015) Jennifer R. Brown et al. BLOOD
- PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
- (2015) F. McClanahan et al. BLOOD
- Familial predisposition and genetic risk factors for lymphoma
- (2015) J. R. Cerhan et al. BLOOD
- Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
- (2015) P. A. Thompson et al. BLOOD
- Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
- (2015) R. Guieze et al. BLOOD
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
- A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
- (2015) H. S. Walter et al. BLOOD
- Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
- (2015) D. Rossi et al. BLOOD
- Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
- (2015) P. Strati et al. BLOOD
- Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
- (2015) P. A. Thompson et al. BLOOD
- Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
- (2015) K. Fischer et al. BLOOD
- Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
- (2015) V. Ljungstrom et al. BLOOD
- Mycophenolate mofetil therapy for severe immune thrombocytopenia
- (2015) Alice Taylor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
- (2015) Philip A. Thompson et al. CANCER
- Racial differences in three major NHL subtypes: Descriptive epidemiology
- (2015) Yang Li et al. Cancer Epidemiology
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
- (2015) C. U. Niemann et al. CLINICAL CANCER RESEARCH
- Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
- (2015) F. Cervantes-Gomez et al. CLINICAL CANCER RESEARCH
- Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century
- (2015) Dianne Pulte et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
- (2015) Peter Hillmen et al. LANCET
- Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome
- (2015) F P Tambaro et al. LEUKEMIA
- Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
- (2015) F R Mauro et al. LEUKEMIA
- Management of adverse events associated with idelalisib treatment: expert panel opinion
- (2015) Steven E. Coutré et al. LEUKEMIA & LYMPHOMA
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
- (2015) Drew C. Deniger et al. PLoS One
- TCL1targetingmiR-3676is codeleted with tumor protein p53 in chronic lymphocytic leukemia
- (2015) Veronica Balatti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
- (2015) Filomena De Falco et al. Oncotarget
- Autoimmune cytopenias in chronic lymphocytic leukemia
- (2014) Carlo Visco et al. AMERICAN JOURNAL OF HEMATOLOGY
- MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia
- (2014) B. Cui et al. BLOOD
- Somatic mutation as a mechanism of Wnt/ -catenin pathway activation in CLL
- (2014) L. Wang et al. BLOOD
- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53
- (2014) J.-F. Fecteau et al. BLOOD
- Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
- (2014) Dan A. Landau et al. CANCER CELL
- New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment Paradigms
- (2014) F. T. Awan et al. CLINICAL CANCER RESEARCH
- The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy
- (2014) G. Packham et al. HAEMATOLOGICA
- Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
- (2014) Fatima Dhalla et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium
- (2014) Danelle F. James et al. JOURNAL OF CLINICAL ONCOLOGY
- CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
- (2014) Pietro Bulian et al. JOURNAL OF CLINICAL ONCOLOGY
- Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
- (2014) A Veronese et al. LEUKEMIA
- The impact of SF3B1 mutations in CLL on the DNA-damage response
- (2014) G D te Raa et al. LEUKEMIA
- A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
- (2014) A C Queirós et al. LEUKEMIA
- The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era
- (2014) Chadi Nabhan et al. LEUKEMIA & LYMPHOMA
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
- (2014) F. Damm et al. Cancer Discovery
- Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
- (2013) V. Coelho et al. BLOOD
- Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
- (2013) E. Chigrinova et al. BLOOD
- A role for IRF4 in the development of CLL
- (2013) V. Shukla et al. BLOOD
- TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
- (2013) P. Dreger et al. BLOOD
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab
- (2013) Joseph Adrian Lumawig Buensalido et al. Expert Review of Anti-Infective Therapy
- Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
- (2013) P. G. Ferreira et al. GENOME RESEARCH
- Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
- (2013) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia
- (2013) Lisa M. Baumann Kreuziger et al. LEUKEMIA & LYMPHOMA
- MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia
- (2013) Marek Mraz et al. LEUKEMIA & LYMPHOMA
- Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy
- (2013) Hans Erik Johnsen et al. LEUKEMIA & LYMPHOMA
- Fludarabine: A review of the clear benefits and potential harms
- (2013) Joshua Lukenbill et al. LEUKEMIA RESEARCH
- Charting a dynamic DNA methylation landscape of the human genome
- (2013) Michael J. Ziller et al. NATURE
- A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
- (2013) Helen E Speedy et al. NATURE GENETICS
- Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
- (2013) Sonja I Berndt et al. NATURE GENETICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
- (2013) Wan-Ling Hsu et al. RADIATION RESEARCH
- Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
- (2013) C. C. Oakes et al. Cancer Discovery
- Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
- (2013) Dan A Landau et al. Genome Medicine
- Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
- (2012) A. Agathangelidis et al. BLOOD
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
- (2012) M. F. M. de Rooij et al. BLOOD
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: Any role for Notch, Wnt and Hh signaling pathways?
- (2012) Paul Faustin Seke Etet et al. CELLULAR SIGNALLING
- Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
- (2012) Lirong Pei et al. Epigenetics
- Bendamustine for treatment of chronic lymphocytic leukemia
- (2012) Julie Elizabeth Chang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2012) Xavier C. Badoux et al. JOURNAL OF CLINICAL ONCOLOGY
- 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
- (2012) N Cahill et al. LEUKEMIA
- NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
- (2012) N Villamor et al. LEUKEMIA
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
- (2012) Marta Kulis et al. NATURE GENETICS
- Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
- (2011) Daisy Alapat et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL
- (2011) S. Decker et al. BLOOD
- Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia
- (2011) X. C. Badoux et al. BLOOD
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment
- (2011) Kate Hodgson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
- (2011) Bruno Bockorny et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia
- (2011) Issa F. Khouri et al. CANCER
- The Pax-5 Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer Disease
- (2011) P. O'Brien et al. CANCER RESEARCH
- Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
- (2011) Krzysztof Giannopoulos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy
- (2011) Shannon K. O'Neill et al. IMMUNITY
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1
- (2011) P Liu et al. LEUKEMIA
- Unknown
- (2011) Carlo Calissano et al. MOLECULAR MEDICINE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
- (2010) T. Tadmor et al. ANNALS OF ONCOLOGY
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
- (2010) S. L. Slager et al. BLOOD
- Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus
- (2010) Joseph M. Flynn et al. BRITISH JOURNAL OF HAEMATOLOGY
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- Molecular underpinning of B-cell anergy
- (2010) Yuval Yarkoni et al. IMMUNOLOGICAL REVIEWS
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
- (2010) T D Shanafelt et al. LEUKEMIA
- Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
- (2010) Dalemari Crowther-Swanepoel et al. NATURE GENETICS
- Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis
- (2010) Morgan O'Hayre et al. PLoS One
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
- (2009) A. Vlad et al. CANCER RESEARCH
- Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection
- (2008) E. M. Ghia et al. BLOOD
- FMC7 is an epitope of CD20
- (2008) J. P. Deans et al. BLOOD
- Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
- (2008) A. Ferrajoli et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
- (2008) J E Castro et al. LEUKEMIA
- A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
- (2008) Maria Chiara Di Bernardo et al. NATURE GENETICS
- Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
- (2008) Andy C. Rawstron et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started